2018 annual financial data

Sarepta Therapeutics 2018 Net margin

Sarepta Therapeutics 2018 net margin with verified reported values.

Direct answer

Net margin was -120.22%.

Operating income was -343,628,000 USD and net income was -361,918,000 USD.
Operating cash flow was -388,660,000 USD.

Get free Sarepta Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
301,034,000 USD
Operating income
-343,628,000 USD
Net income
-361,918,000 USD
Operating cash flow
-388,660,000 USD